Related Experiment Video
Updated: Jan 27, 2026

Isolation and Culture of Adult Mouse Cardiomyocytes for Cell Signaling and in vitro Cardiac Hypertrophy
Published on: May 21, 2014
Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
Rajinikanth Gogiraju1,2,3,4, Magdalena L Bochenek2,3,4, Katrin Schäfer1,2,3,4
1Center for Cardiology, Cardiology I, Translational Vascular Biology, University Medical Center Mainz, Mainz, Germany.
Insights
Cardiac hypertrophy impairs blood vessel growth, leading to heart failure. This review explores how endothelial cells, angiogenesis regulators, and cellular stress contribute to vascular dysfunction and heart disease progression.
Area of Science:
- Cardiovascular Biology
- Cellular and Molecular Medicine
- Pathophysiology
Background:
- Endothelial cells are crucial for heart function and disease.
- Reduced cardiac capillary density leads to hypoxia, cell death, and fibrosis, contributing to heart failure.
- Molecular mechanisms of inadequate cardiac vascularization during pathological hypertrophy are not fully understood.
Purpose of the Study:
- To review vascular changes during cardiac hypertrophy and transition to heart failure.
- To summarize findings on factors regulating cardiac angiogenesis in preclinical models.
- To discuss signaling pathways in endothelial cells and their disruption by stress.
Main Methods:
- Review of preclinical models (transgenic mice, experimental hypertrophy).
- Analysis of paracrine regulation of cardiac angiogenesis by various cell types.
- Discussion of signaling events in endothelial cells, including negative regulators.
Main Results:
- Identified factors from cardiomyocytes, pericytes, and inflammatory cells influencing angiogenesis.
- Highlighted roles of protein tyrosine phosphatase-1B and tumor suppressor p53 in angiogenesis regulation.
- Discussed how hypoxia and oxidative stress disrupt angiogenic signaling in endothelial cells.
Conclusions:
- Endothelial cell dysfunction, including death and myofibroblast-like conversion, contributes to cardiac fibrosis and heart failure.
- Dysfunctional endothelial cells secrete factors that negatively impact cardiomyocytes, exacerbating heart remodeling.
- Reciprocal interactions between endothelial cells and cardiomyocytes form a vicious cycle in pathological hypertrophy.
Abstract:
Endothelial cells are, by number, one of the most abundant cell types in the heart and active players in cardiac physiology and pathology. Coronary angiogenesis plays a vital role in maintaining cardiac vascularization and perfusion during physiological and pathological hypertrophy. On the other hand, a reduction in cardiac capillary density with subsequent tissue hypoxia, cell death and interstitial fibrosis contributes to the development of contractile dysfunction and heart failure, as suggested by clinical as well as experimental evidence. Although the molecular causes underlying the inadequate (with respect to the increased oxygen and energy demands of the hypertrophied cardiomyocyte) cardiac vascularization developing during pathological hypertrophy are incompletely understood. Research efforts over the past years have discovered interesting mediators and potential candidates involved in this process. In this review article, we will focus on the vascular changes occurring during cardiac hypertrophy and the transition toward heart failure both in human disease and preclinical models. We will summarize recent findings in transgenic mice and experimental models of cardiac hypertrophy on factors expressed and released from cardiomyocytes, pericytes and inflammatory cells involved in the paracrine (dys)regulation of cardiac angiogenesis. Moreover, we will discuss major signaling events of critical angiogenic ligands in endothelial cells and their possible disturbance by hypoxia or oxidative stress. In this regard, we will particularly highlight findings on negative regulators of angiogenesis, including protein tyrosine phosphatase-1B and tumor suppressor p53, and how they link signaling involved in cell growth and metabolic control to cardiac angiogenesis. Besides endothelial cell death, phenotypic conversion and acquisition of myofibroblast-like characteristics may also contribute to the development of cardiac fibrosis, the structural correlate of cardiac dysfunction. Factors secreted by (dysfunctional) endothelial cells and their effects on cardiomyocytes including hypertrophy, contractility and fibrosis, close the vicious circle of reciprocal cell-cell interactions within the heart during pathological hypertrophy remodeling.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies

